News
VERU
1.210
-8.33%
-0.110
VERU INC: ON APRIL 23, RECEIVED NOTIFICATION LETTER FROM NASDAQ CONFIRMING THAT CO REGAINED COMPLIANCE
Reuters · 17h ago
MILLENNIUM MANAGEMENT LLC REPORTS 5.2% PASSIVE STAKE IN VERU INC AS OF APRIL 18 - SEC FILING
Reuters · 1d ago
Weekly Report: what happened at VERU last week (0415-0419)?
Weekly Report · 3d ago
LI, VERU and MRIN among pre-market losers
Seeking Alpha · 6d ago
Veru, EyePoint Pharmaceuticals, SINTX Technologies among healthcare movers
Seeking Alpha · 04/18 14:00
What Makes Veru (VERU) a New Buy Stock
NASDAQ · 04/17 16:00
3 Standout Penny Stocks to Watch This April
Penny stocks are stocks that trade for less than $5 per share. Ocugen, Inc. (OCGN), Veru Inc (VERU), and Desktop Metal, Inc (DM) are three outperforming penny stocks trading under $2. Veru Veru stock has surged 82.6% on a YTD basis, but is 31% below its 52-week high.
Barchart · 04/16 12:34
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Ultragenyx Pharmaceutical shares dipped 9.4% to $42.46 on Monday. The company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome. Soligenix, Inc. Shares surged 71.5% after the company was granted orphan drug designation for MarVax.
Benzinga · 04/15 18:11
VERU <VERU.O>: OPPENHEIMER CUTS TARGET PRICE TO $5 FROM $7
Reuters · 04/15 13:06
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Wells Fargo boosted the price target for Centene Corporation from $89 to $93. Charter Communications, Inc. And Notable Labs, Ltd. Also saw their price targets cut. The price target of Veru Inc. Was slashed from $7 to $5.
Benzinga · 04/15 12:39
Oppenheimer Reiterates Outperform on Veru, Lowers Price Target to $5
Benzinga · 04/15 11:55
Weekly Report: what happened at VERU last week (0408-0412)?
Weekly Report · 04/15 11:26
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
JPMorgan Chase & Co. Shares dipped 5.1% to $185.49 following first-quarter earnings on Friday. PaxMedica, Inc. Shares jumped 143% after the company reported better-than-expected results on Thursday. Rent the Runway shares jumped 162% on Thursday after reporting mixed results.
Benzinga · 04/12 18:47
Veru, Theravance Biopharma, Adial Pharmaceuticals among healthcare movers
Seeking Alpha · 04/12 14:00
NKTR, VERU and EGIO among mid-day movers
U.S. Economy NKTR, VERU and EGIO among mid-day movers. Rent the Runway (RENT) and Rallybio Corp are among the gainers. Aptevo Therapeutics (NA) is one of the biggest losers.
Seeking Alpha · 04/11 16:55
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
Farmer Bros (NASDAQ:FARM) stock increased by 4.8% to $3.48 during Tuesday's after-market session. Pricesmart stock moved upwards by four percent to $86.99. The company's, Q2 earnings came out today.
Benzinga · 04/09 20:31
Weekly Report: what happened at VERU last week (0401-0405)?
Weekly Report · 04/08 11:30
VERU-CONCLUDED DISCLOSURE CONTROLS,PROCEDURES NOT EFFECTIVE AS OF DEC 31, 2023 DUE TO MATERIAL WEAKNESSES IN INTERNAL CONTROL OVER FINANCIAL REPORTING
Reuters · 04/01 19:59
Weekly Report: what happened at VERU last week (0325-0329)?
Weekly Report · 04/01 11:28
Veru Initiated at Outperform by Raymond James
Dow Jones · 03/28 10:19
More
Webull provides a variety of real-time VERU stock news. You can receive the latest news about Veru through multiple platforms. This information may help you make smarter investment decisions.
About VERU
Veru Inc. is a biopharmaceutical company. The Company is focused on developing medicines for the for the treatment of hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and other viral-related ARDS and for the management of breast and prostate cancers. The Company offers two FDA approved products within its sexual health program, including ENTADFI (tadalafil 5mg and finasteride 5mg capsule), for the treatment of benign prostatic hyperplasia and FC2 Female Condom (internal condom) (FC2), for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. Its breast cancer drug pipeline has four clinical development programs for two drugs, such as enobosarm, an oral selective androgen receptor targeting agonist, and sabizabulin, an oral cytoskeleton disruptor. Its prostate cancer drug pipeline includes sabizabulin, VERU-100 and zuclomiphene citrate.